[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology [BioMed Central]
卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
流光发布了新的文献求助10
刚刚
啦啦啦完成签到,获得积分10
1秒前
zdh发布了新的文献求助30
1秒前
CipherSage应助伽俽采纳,获得10
1秒前
1秒前
onedowmsk完成签到,获得积分10
1秒前
1秒前
Glume发布了新的文献求助10
1秒前
科研混子完成签到,获得积分10
1秒前
Jalin完成签到 ,获得积分10
1秒前
随遇而安发布了新的文献求助10
2秒前
dalei001完成签到 ,获得积分10
2秒前
科研通AI2S应助海豚采纳,获得10
3秒前
江和海完成签到 ,获得积分10
3秒前
3秒前
花椒泡茶发布了新的文献求助10
4秒前
量子星尘发布了新的文献求助10
4秒前
One完成签到,获得积分10
5秒前
6秒前
JCSY发布了新的文献求助30
6秒前
开朗青枫发布了新的文献求助10
6秒前
温仕宏发布了新的文献求助20
6秒前
7秒前
打打应助1123采纳,获得10
7秒前
科目三应助一人采纳,获得10
7秒前
Nora发布了新的文献求助10
7秒前
7秒前
7秒前
One发布了新的文献求助10
8秒前
山月完成签到,获得积分10
8秒前
852应助sai采纳,获得10
8秒前
8秒前
LAVINE完成签到 ,获得积分10
8秒前
明明完成签到,获得积分10
8秒前
派大星完成签到,获得积分10
9秒前
大模型应助tyughi采纳,获得10
9秒前
zdh完成签到,获得积分20
10秒前
10秒前
ZJT完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aerospace Standards Index - 2026 ASIN2026 3000
Relation between chemical structure and local anesthetic action: tertiary alkylamine derivatives of diphenylhydantoin 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Work Engagement and Employee Well-being 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6067851
求助须知:如何正确求助?哪些是违规求助? 7899857
关于积分的说明 16328412
捐赠科研通 5209572
什么是DOI,文献DOI怎么找? 2786550
邀请新用户注册赠送积分活动 1769457
关于科研通互助平台的介绍 1647899